a public good project by the
Synthesis
Company
of California

© 2026

Carol D. Weiss | doi.page

0 works0 citations0 h-index

Carol D. Weiss

Center for Biologics Evaluation and Research(US)United States Food and Drug Administration(US)

Publications by Year

Research Areas

SARS-CoV-2 and COVID-19 Research, HIV Research and Treatment, Influenza Virus Research Studies, Respiratory viral infections research, HIV/AIDS drug development and treatment

Most-Cited Works

→ Capture of an early fusion-active conformation of HIV-1 gp41(1998)497 cited
→ Isolates of human immunodeficiency virus type 1 from the brain may constitute a special group of the AIDS virus.(1989)232 cited
→ Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meeting(2019)201 cited
→ Oligomeric organization of gp120 on infectious human immunodeficiency virus type 1 particles(1990)161 cited
→ Thiol/disulfide exchange is a prerequisite for CXCR4-tropic HIV-1 envelope-mediated T-cell fusion during viral entry(2003)143 cited
→ Long survival in a 69,XXY triploid male(1986)141 cited

→ Establishment of a well-characterized SARS-CoV-2 lentiviral pseudovirus neutralization assay using 293T cells with stable expression of ACE2 and TMPRSS2(2021)

140 cited

→ Peptides Trap the Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Fusion Intermediate at Two Sites(2003)138 cited

→ Dissection of Human Immunodeficiency Virus Type 1 Entry with Neutralizing Antibodies to gp41 Fusion Intermediates(2002)122 cited

→ Optimal conditions for recovery of the human immunodeficiency virus from peripheral blood mononuclear cells(1988)112 cited